Literature DB >> 8823368

Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes.

Y V Ezepchuk1, D Y Leung, M H Middleton, P Bina, R Reiser, D A Norris.   

Abstract

It has been proposed that toxins and other bacterial protein products of Staphylococcus aureus can act as triggers or persistence factors in several inflammatory skin diseases. In this study, we examined the S. aureus isolates from the skin of patients with atopic dermatitis and psoriasis. We found that the bacterial isolates from these patients exhibited either characteristic superantigenic toxins or thermolabile toxins believed to be staphylococcal alpha-toxin. All of these staphylococcal strains also secreted extracellular staphylococcal protein A. We found significant differences in the action of these toxins on human keratinocytes and keratinocyte cell lines. The superantigenic toxins toxic shock syndrome toxin-1, staphylococcal enterotoxins A and B, and exfoliative toxin-A, as well as staphylococcal protein A, did not induce significant cytotoxic damage in the keratinocyte cell line HaCaT, whereas the staphylococcal alpha-toxin produced profound cytotoxicity. Keratinocyte cytotoxicity induced by staphylococcal alpha-toxin was time and concentration dependent and demonstrated the morphologic and functional characteristics of necrosis, not apoptosis. Addition of alpha-toxin to keratinocytes simultaneously induced cell lysis and tumor necrosis factor-alpha release into the medium within 30 min; apparently, it was constitutive tumor necrosis factor-alpha. On the other hand, superantigenic toxins and, in particular, protein A showed stimulation of tumor necrosis factor-alpha secretion in keratinocytes and release of this cytokine after 6-12 h of incubation. Thus, staphylococcal protein A, alpha-toxin, and superantigenic toxins found in S. aureus isolates from patients with psoriasis and atopic dermatitis can produce direct pro-inflammatory effects on keratinocytes through the release of tumor necrosis factor-alpha. We propose that these effects may be relevant to the induction and persistence of lesions in these two diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823368     DOI: 10.1111/1523-1747.ep12583377

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

1.  Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

Authors:  J B Travers; Q A Hamid; D A Norris; C Kuhn; R C Giorno; P M Schlievert; E R Farmer; D Y Leung
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 3.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

5.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

6.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Identification of staphylococcal protein A in infected atopic dermatitis lesions.

Authors:  Yongxue Yao; Amal Kozman; Mohammed Al-Hassani; Chandan K Saha; Qiaofang Yi; Weiguo Yao; Nico Mousdicas; Mark H Kaplan; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2010-06-03       Impact factor: 8.551

8.  Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid.

Authors:  Jeffrey B Travers; Amal Kozman; Nico Mousdicas; Chandan Saha; Megan Landis; Mohammed Al-Hassani; Weiguo Yao; Yongxue Yao; Ann-Marie Hyatt; Michael P Sheehan; Anita N Haggstrom; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2009-12-04       Impact factor: 10.793

9.  Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes.

Authors:  Kyu Han Kim; Ji Hyun Han; Jin Ho Chung; Kwang Hyun Cho; Hee Chul Eun
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

Review 10.  Role of bacterial pathogens in atopic dermatitis.

Authors:  Yu-Tsan Lin; Chen-Ti Wang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.